The science behind demineralized bone matrix
How removing the mineral from bone leaves behind exactly what makes a graft work.
Last updated: July 2026
Demineralized bone matrix (DBM) starts as donor bone processed with an acidic solution that removes the mineral (calcium-based) component while leaving the organic matrix intact — primarily type I collagen, along with non-collagen proteins and naturally occurring osteoinductive growth factors, including bone morphogenetic proteins (BMPs).
That combination gives DBM two distinct properties. It’s osteoconductive — its structure acts as a scaffold that new bone can grow into and along. And because demineralization exposes the BMPs previously locked in the mineral matrix, it’s also osteoinductive — capable of actively signaling the recipient’s cells to form new bone, rather than just providing a passive scaffold. That dual mechanism is why DBM has become a standard option across spinal, orthopedic, and craniofacial procedures, often used alongside autograft, bone marrow, or ceramic carriers.
One well-documented caveat in the literature: because BMP content is biologically variable, osteoinductive potency can differ between donors and even between batches from the same donor — part of why traceability and batch documentation on every graft matters as much as the material itself.
Sources
Demineralized Bone Matrix Carriers and their Clinical Applications: An Overview (PMC) · Demineralized bone matrix in bone repair: History and use (PMC)